Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction.

25 This finding was coupled with a highly significant decline in the number of in-hospital days compared with the year before BAT and persisted after 21 months of follow-up. 26 On the VNS side, the background pathophysiology was documented at the experimental level only and then brought into the clinical arena by Schwartz et al. 3 in a feasibility study in eight patients with advanced heart failure.

also in 132,142 other papers